Based on the observed reduced expression of RBPMS in the cisplatin-resistant ovarian cancer cells (Figure 1E), we next aimed to determine whether RBPMS knockout reduced the sensitivity of ovarian cancer cells to cisplatin treatment. Here, RBPMS is linked to ovarian cancer.